Total Non-Current Liabilities

$1.17B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$505.98Mperiod endingDec 31, 2025

LGND FY Total Non-Current Liabilities ($12.30M → $505.98M)

Annual total non-current liabilities

High-resolution chart · PNG

LGND total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	505,977,999
Dec 31, 2024	74,223,000
Dec 31, 2023	69,521,000
Dec 31, 2022	66,373,000
Dec 31, 2021	434,766,000
Dec 31, 2020	552,649,000
Dec 31, 2019	710,681,000
Dec 31, 2018	617,640,000
Dec 31, 2017	13,506,000
Dec 31, 2016	3,603,000
Dec 31, 2015	208,702,000
Dec 31, 2014	210,842,000
Dec 31, 2013	26,161,000
Dec 31, 2012	42,336,000
Dec 31, 2011	70,061,000
Dec 31, 2010	46,920,000
Dec 31, 2009	57,783,000
Dec 31, 2008	111,199,000
Dec 31, 2007	93,195,000
Dec 31, 2006	127,891,000
Dec 31, 2005	189,827,000
Dec 31, 2004	191,071,000
Dec 31, 2003	176,478,000
Dec 31, 2002	166,059,000
Dec 31, 2001	143,622,000
Dec 31, 2000	140,132,000
Dec 31, 1999	139,500,000
Dec 31, 1998	140,500,000
Dec 31, 1997	51,400,000
Dec 31, 1996	53,800,000
Dec 31, 1995	49,800,000
Dec 31, 1994	12,300,000